ArticleCancers2022

Real-World Data on Ramucirumab Therapy including Patients Who Experienced Two or More Systemic Treatments: A Multicenter Study.

Yutaka Yasui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.